United Therapeutics (UTHR) Inventory (2009 - 2026)

United Therapeutics (UTHR) has 18 years of Inventory data on file, last reported at $178.3 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 7.8% year-over-year to $178.3 million; the trailing twelve-month figure through Mar 2026 stood at $178.3 million (up 7.8% YoY), and the FY2025 full-year result was $183.1 million, up 15.96% from the prior year.
• Inventory fell to $178.3 million in Q1 2026, from $183.1 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $183.1 million in Q4 2025 to a low of $88.2 million in Q1 2022.
• A 5-year average of $131.0 million and a median of $120.2 million in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory retreated 5.89% in 2022 and jumped 41.23% in 2024, its largest moves.
• Tracing UTHR's Inventory over 5 years: stood at $102.0 million in 2022, then grew by 9.61% to $111.8 million in 2023, then jumped by 41.23% to $157.9 million in 2024, then gained by 15.96% to $183.1 million in 2025, then decreased by 2.62% to $178.3 million in 2026.
• Business Quant data shows UTHR's Inventory at $178.3 million in Q1 2026, $183.1 million in Q4 2025, and $176.5 million in Q3 2025.